BioCentury | May 14, 2012
Company News

Takeda gastrointestinal news

...the pharma under-allocated its U.S. earnings in relation to transactions of Prevacid between Takeda and Tap Pharmaceutical Products Inc....
BioCentury | Apr 16, 2012
Company News

Takeda gastrointestinal news

...U.S. earnings in relation to product supply and license transactions of Prevacid between Takeda and Tap Pharmaceutical Products Inc....
BioCentury | Apr 4, 2011
Company News

CSL, Abbott, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Merck, Pfizer, sanofi-aventis, Takeda pharmaceuticals news

...and sanofi-aventis. CSL's ZLB Behring LLC subsidiary was also named in the suit, as was Tap Pharmaceutical Products Inc....
BioCentury | Oct 4, 2010
Company News

CSL, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Pfizer, sanofi-aventis pharmaceuticals news

...Pfizer, argue that the entities do not have standing to sue under the 340B statute. Tap Pharmaceutical Products Inc....
BioCentury | May 11, 2009
Company News

Shire, Takeda, Teva deal

...Shire said the termination was for strategic reasons. The original deal was between Shire and Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 5, 2008
Company News

Abbott, Takeda deal

...Abbott and Takeda completed the previously announced closing of their Tap Pharmaceutical Products Inc. JV (see BioCentury, March 24...
BioCentury | Mar 31, 2008
Company News

Shire, Tap Pharmaceutical sales and marketing update

...and the Pacific Rim from Giuliani S.p.A. (Milan, Italy). Shire plc (LSE:SHP; NASDAQ:SHPGY), Basingstoke, U.K. Tap Pharmaceutical Products Inc....
Items per page:
1 - 10 of 82
BioCentury | May 14, 2012
Company News

Takeda gastrointestinal news

...the pharma under-allocated its U.S. earnings in relation to transactions of Prevacid between Takeda and Tap Pharmaceutical Products Inc....
BioCentury | Apr 16, 2012
Company News

Takeda gastrointestinal news

...U.S. earnings in relation to product supply and license transactions of Prevacid between Takeda and Tap Pharmaceutical Products Inc....
BioCentury | Apr 4, 2011
Company News

CSL, Abbott, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Merck, Pfizer, sanofi-aventis, Takeda pharmaceuticals news

...and sanofi-aventis. CSL's ZLB Behring LLC subsidiary was also named in the suit, as was Tap Pharmaceutical Products Inc....
BioCentury | Oct 4, 2010
Company News

CSL, AstraZeneca, Bayer, Bristol-Myers, GlaxoSmithKline, Pfizer, sanofi-aventis pharmaceuticals news

...Pfizer, argue that the entities do not have standing to sue under the 340B statute. Tap Pharmaceutical Products Inc....
BioCentury | May 11, 2009
Company News

Shire, Takeda, Teva deal

...Shire said the termination was for strategic reasons. The original deal was between Shire and Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 26, 2008
Clinical News

TAK-390MR: Phase III data

...maintain healing of EE is under FDA review. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Tap Pharmaceutical Products Inc....
BioCentury | May 5, 2008
Company News

Abbott, Takeda deal

...Abbott and Takeda completed the previously announced closing of their Tap Pharmaceutical Products Inc. JV (see BioCentury, March 24...
BioCentury | Mar 31, 2008
Company News

Shire, Tap Pharmaceutical sales and marketing update

...and the Pacific Rim from Giuliani S.p.A. (Milan, Italy). Shire plc (LSE:SHP; NASDAQ:SHPGY), Basingstoke, U.K. Tap Pharmaceutical Products Inc....
Items per page:
1 - 10 of 82